Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In quest of a new therapeutic approach in COVID-19: the endocannabinoid system
Ondine Lucaciu, Ovidiu Aghiorghiesei, Nausica Bianca Petrescu, et al.
Drug Metabolism Reviews (2021) Vol. 53, Iss. 4, pp. 478-490
Open Access | Times Cited: 24

Showing 24 citing articles:

Antimicrobial Potential of Cannabinoids: A Scoping Review of the Past 5 Years
Maria João Coelho, Maria Araújo, Márcia Carvalho, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 325-325
Open Access
Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19
Alish B. Palmos, Vincent Millischer, David Menon, et al.
PLoS Genetics (2022) Vol. 18, Iss. 3, pp. e1010042-e1010042
Open Access | Times Cited: 29
Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection
Marcin Janecki, Michał Graczyk, Agata Anna Lewandowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4170-4170
Open Access | Times Cited: 27
Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
Md Sultan Mahmud, Mohammad Sorowar Hossain, A T M Faiz Ahmed, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7216-7216
Open Access | Times Cited: 25
Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers
Naama Karu, Alida Kindt, Lieke Lamont, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 619-619
Open Access | Times Cited: 17
Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment
Rebeca Pérez, Talita Glaser, Cecilia Villegas, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2117-2117
Open Access | Times Cited: 14
Tick-borne encephalitis virus transmitted singly and in duo with Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum bacteria by ticks as pathogens modifying lipid metabolism in human blood
Marta Dobrzyńska, Anna Moniuszko‐Malinowska, Piotr Radziwon, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 2
Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations
Jamie Holmes, Shahidul M. Islam, Kimberly Milligan
Viruses (2024) Vol. 16, Iss. 6, pp. 878-878
Open Access | Times Cited: 2
The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19
Jonatan C. S. de Carvalho, Pedro V. da Silva‐Neto, Diana Mota Toro, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 573-573
Open Access | Times Cited: 6
Circulating endocannabinoid levels in SARS-CoV-2 infection and their potential role in the inflammatory response
María Velasco, María Posada-Ayala, Elia Pérez‐Fernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Redox Imbalance and Its Metabolic Consequences in Tick-Borne Diseases
Monika Groth, Elżbieta Skrzydlewska, Marta Dobrzyńska, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 7
Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
Ahmet Onay, Abdülselam Ertaş, Veysel Süzerer, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 570-587
Open Access | Times Cited: 9
Endocannabinoids, Anandamide and 2-Arachidonoylglycerol, as Prognostic Markers of Sepsis Outcome and Complications
Ines Šahinović, Sanja Mandić, Damir Mihić, et al.
Cannabis and Cannabinoid Research (2022) Vol. 8, Iss. 5, pp. 802-811
Open Access | Times Cited: 5
Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets
Fatemeh Aghamahdi, Arman Shafiee, Sayeh Rostami, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 5, pp. 102499-102499
Open Access | Times Cited: 4
N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARα
Lisa E. Flannery, Daniel M. Kerr, Edel M. Hughes, et al.
Journal of Neuroimmunology (2021) Vol. 358, pp. 577654-577654
Open Access | Times Cited: 5
Strengthening pharmacotherapy research for COVID-19-induced pulmonary fibrosis
Yan-Miao Liu, Jing Zhang, Jingjing Wu, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 5, pp. 875-879
Open Access
Probing molecular pathways: Illuminating the connection between COVID‐19 and Alzheimer's disease through the endocannabinoid system dynamics
Sun Q, Jinyang Gao, Ran An, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access
The role of pre-onset hair hormone in predicting the prognosis of patients with severe pneumonia and acute COVID-19 outbreak
Yuanyuan Jia, Deyi Qi, Tiantian Wang, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30636-e30636
Open Access
Antiviral properties of cannabidiol for the management of COVID-19
Isaac Thom Shawa
Elsevier eBooks (2024), pp. 137-151
Closed Access
Substances of abuse and their effect on SAR-CoV-2 pathogenesis
Ivy Antwi, Destiny Watkins, Alahn Pedawi, et al.
NeuroImmune Pharmacology and Therapeutics (2023) Vol. 2, Iss. 3, pp. 301-316
Open Access | Times Cited: 1
Scientific Evaluation of Dhuma Yoga (An Ayurvedic Fumigation Medicine) as Preventive and Curative on Symptoms of Covid-19 Disease
Siva Ram
International Journal of Ayurveda and Pharma Research (2021), pp. 49-61
Open Access | Times Cited: 1
The Endocannabinoid System as Prognostic Biomarker of the Obstructive Sleep Apnea Morbidity in COVID-19-Recovered Individuals
Eric Murillo‐Rodríguez
Sleep and Vigilance (2021) Vol. 5, Iss. 2, pp. 205-211
Open Access | Times Cited: 1
Immune Modulating Theorem of Vijaya Ghrita, A Fast Acting Ayurvedic Cannabis Formulation for Treating Covid-19 Disease Symptoms
G. S. Ram
International Research Journal of Ayurveda & Yoga (2022) Vol. 04, Iss. 12, pp. 115-124
Open Access
CONCEPTUAL REVIEW ON THE POTENTIAL OF PUNARNAVADYA GHRITA IN TACKLING THE SYMPTOMS OF COVID-19
G. S. Ram
International Journal of Research in Ayurveda and Pharmacy (2021) Vol. 12, Iss. 3, pp. 157-163
Open Access
Page 1

Scroll to top